AzTrials
AzTrials

HypoglycemiaNCT02909881

Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes

A study testing Use of PhytoSpherix at 0 g/min, Use of PhytoSpherix at 1 g/min and Use of PhytoSpherix at 1.5 g/min in people with Hypoglycemia, run by University of Western Ontario, Canada at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

PhytoSpherix (Phx) is an all-natural, edible polysaccharide extracted from sweet corn. This carbohydrate is the major muscle fuel for intense exercise and its stores are quite small such that one can run out of it during a single exercise bout. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
Conditions the study is for
Hypoglycemia
What is being tested?
Use of PhytoSpherix at 0 g/min, Use of PhytoSpherix at 1 g/min and Use of PhytoSpherix at 1.5 g/min
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteCanada
Study dates
Sep 2016to Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy male endurance trained athletes with >2 y cycling experience; about 2 h/day

Who cannot join

  • Unhealthy athletes, smokers

Trial locations and contacts

1 site in 1 country.

Peter Lemon, PhD contact

519 661 2111 ext. 88139

plemon@uwo.ca

Arash Bandegan, PhD contact

519 661 2111 ext. 88139

abandega@uwo.ca

Canada1 site
  • Exercise Nutrition Research Laboratory, Western University

    London, Ontario, N6A 3K7

Other trials in Canada

About this study

Official title: Dose Response Oxidation of a Sweet-corn Derived Polysaccharide (PhytoSpherix) During Exercise in Endurance Trained Athletes

PhytoSpherix (Phx) is an all-natural, edible polysaccharide extracted from sweet corn. This carbohydrate is the major muscle fuel for intense exercise and its stores are quite small such that one can run out of it during a single exercise bout. Therefore, Phx should provide significant exercise fuel if consumed during exercise. As a result its intake could enhance intense exercise performance by providing additional fuel. This experiment Will investigate the effects of 4 different dosages of Phx consumed throughout a prolonged exercise bout on carbohydrate and fat utilization as well as its oxidation rate and perception of effort during prolonged intense exercise in trained cyclists. Muscle and liver carbohydrate stores will be examined using a non-invasive ultrasound technique.

Read the detailed description

Carbohydrate (CHO) is one of the main substrate oxidized during moderate-to-high intensity, endurance-type exercise. It's been shown that CHO feeding during exercise enhances endurance performance and capacity, attributed mainly to the facilitation of greater rates of exogenous CHO oxidation, prevention of hypoglycaemia and sparing of muscle glycogen. Previous studies based on supplementation of glucose during 180 min. of cycling exercise have reported a maximal rate of exogenous CHO oxidation to be about 1 g/min. Other studies have shown that CHO oxidation rates can reach peak values of about 1.3 g/min when a combination of fructose and glucose is ingested at a rate of 1.8 g/min. The limitation in uptake and oxidation of a single CHO source is attributed to its intestinal transporter saturation such that when multiple CHO source is used the uptake and oxidation rate is increased to a greater extent. Currently there is no information regarding Phx uptake or oxidation rate as a CHO source during exercise. Also, it is important to investigate whether Phx as a CHO sport drink can increase performance by sparing muscle and liver glycogen during exercise. Therefore, the objective of this experiment is to measure dose response of Phx oxidation rate during prolonged cycling exercise and its effect on muscle and liver glycogen levels.

Conditions
Hypoglycemia
Being tested
Use of PhytoSpherix at 0 g/min, Use of PhytoSpherix at 1 g/min, Use of PhytoSpherix at 1.5 g/min, Use of PhytoSpherix at 2 g/min, Cycling exercise
Keywords
polysaccharide, oxidation, endurance exercise
Medical subject headings
Hypoglycemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Use of PhytoSpherix at 0 g/minDietary supplement

    PhytoSpherix (Sweet-corn derived sugar) will be fed at 0 g/min during a 150 min cycling exercise

  • Use of PhytoSpherix at 1 g/minDietary supplement

    PhytoSpherix (Sweet-corn derived sugar) will be fed at 1 g/min during a 150 min cycling exercise

  • Use of PhytoSpherix at 1.5 g/minDietary supplement

    PhytoSpherix (Sweet-corn derived sugar) will be fed at 1.5 g/min during a 150 min cycling exercise

  • Use of PhytoSpherix at 2 g/minDietary supplement

    PhytoSpherix (Sweet-corn derived sugar) will be fed at 2 g/min during a 150 min cycling exercise

  • Cycling exerciseBehavioural

    Male endurance athletes will complete a cycling exercise for 150 min at 50% of their respective maximum wattage

Study groups in NCT02909881
Study groupRoleWhat they receive
Endurance trained male cyclistsExperimental8 male endurance trained male cyclist will consume varying amounts (0, 1, 1.5 and 2 g/min) of PhytoSpherix (sweet-corn derived sugar) during a 150 min . cycling exercise
Receives: Dietary Supplement: Use of PhytoSpherix at 0 g/min; Dietary Supplement: Use of PhytoSpherix at 1 g/min; Dietary Supplement: Use of PhytoSpherix at 1.5 g/min; Dietary Supplement: Use of PhytoSpherix at 2 g/min; Behavioral: Cycling exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxidation of PhytoSpherixat

    Breath samples will be taken starting at 0, 15, 30, 45, 60, 75, 90, 135, up to 150 min from the beginning of the exercise session to measure change in oxidation of PhytoSpherix

    Measured: 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  2. Noninvasive ultrasound measure of glycogen in Vastus lateralis, rectus femoris and liver

    Change in muscle and liver glycogen will be measured 10 min before and 10 min after exercise session. When muscle and liver glycogen content is high, the ultrasound image is hypoechoic (dark), and with glycogen depletion and water loss, the image is hyperchoic (brighter).Three ultrasound measurements at each site will be made by a trained technician using a 12 MHz linear transducer and a standard diagnostic high resolution GE LOGIQ-e ultrasound machine (GE Healthcare, Milwaukee, WI). After calculating statistics on the color bar to determine the general brightness settings of the machine, images will be pre-processed and segmented to isolate the muscle area under analysis using a center crop within the muscle section 25 mm from the top muscle sheath. Comparing these results will help better understand the effect of supplementation of Phx at different rates on any changes in glycogen stores of muscle and liver.

    Measured: 10 min before and 10 min after the 150 min exercise session

Secondary outcomes (5)
  1. blood glucose concentration

    Changes in blood glucose will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session. A blood drop by finger prick approach starting at time 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session under sterile practice will be used to determine blood glucose concentrations

    Measured: 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  2. blood lactate concentration

    Changes in blood lactate will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session. A blood drop by finger prick approach starting at time 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session under sterile practice will be used to determine blood lactate concentrations

    Measured: 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  3. Respiratory exchange ratio

    Respiratory exchange ratio will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session for periods of 4 min by using an online automated gas-analysis system.

    Measured: At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  4. rate of perceived exertion

    rate of perceived exertion (RPE) for whole body and legs will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session on a scale from 6 to 20, using the Borg category scale.

    Measured: At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  5. questionnaire to rate possible gastrointestinal (GI) problems

    every athlete will be asked at 30, 60, 90, 120 and 150 min from the beginning of the exercise session to fill in a questionnaire to rate possible gastrointestinal (GI) problems including stomach problems, GI cramping, bloated feeling, diarrhea, nausea, dizziness, headache, belching, vomiting, and urge to urinate and defecate. While cyclists are on the bike and continue their exercise, each question will be answered by simply ticking a box on the questionnaire that corresponds to the severity of the GI problem addressed. The items will be scored on a 10-point scale (1 not at all, 10 very, very much).

    Measured: At 30, 60, 90, 120 and 150 min from the beginning of the exercise session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionSep 2017 (estimated)
  4. Study completionSep 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
8 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02909881
Sponsor's protocol ID
10014597
Status last verified
Sep 2016
First submitted
10 Sep 2016
Last updated
22 Sep 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Bandegan A, Huang L, Longstaffe FJ, Lemon PW. Dose-Response Oxidation of Ingested Phytoglycogen during Exercise in Endurance-Trained Men. J Nutr. 2021 Oct 1;151(10):2942-2948. doi: 10.1093/jn/nxab219.

    PubMed 34255078

Questions about this trial

What is this clinical trial studying?

A study testing Use of PhytoSpherix at 0 g/min, Use of PhytoSpherix at 1 g/min and Use of PhytoSpherix at 1.5 g/min in people with Hypoglycemia, run by University of Western Ontario, Canada at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Peter Lemon, PhD (519 661 2111 ext. 88139, plemon@uwo.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxidation of PhytoSpherixat (time frame: 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02909881, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in